TIS Division

Blood and Cell Technologies Company

Terumo Blood and Cell Technologies

Unlocking the potential of blood and cells for patients and their quality of life

Blood and cells are indispensable in sustaining our lives, and at the same time, they hold the potential to treat cancer and other serious diseases. The Blood and Cell Technologies Company, which is headed by the subsidiary Terumo Blood and Cell Technologies, provides devices to safely and efficiently process donated blood into blood products and to collect blood components needed for transfusions and cell therapy. The company also offers automation and workflow efficiency solutions to support pharmaceutical company’s manufacturing process for cell therapies.
The company will continue to advance its unique technologies to provide patients with new treatment options.

Main Products

Note: The regulatory approval status and availability of these products differ by country or region.

Blood Centers Solutions

Blood from donations is processed at blood centers into products including platelets, plasma, and red blood cells, then supplied to medical institutions. Terumo provides blood centers with blood collection instruments, disposable kits, whole blood bags, and devices used to process blood products.

Main Products

Whole blood collection

With leukocyte filter Blood bags

With leukocyte filter Blood bags

Component collection

Component collection system

Component collection system

Blood separation and component production

Automated blood processing system

Automated blood processing system

Pathogen reduction technology

Pathogen reduction system

Pathogen reduction system

Therapeutic Apheresis and Cell Collection

Terumo provides a centrifugal apheresis system that separates, collects, or removes blood components. Through a variety of blood component removal therapies or collection, we provide patients with new treatment options.

Centrifugal apheresis system

Centrifugal apheresis system

Therapeutic Apheresis and Cell Collection

Cell Processing

This technology efficiently processes the cells needed for use in therapy and research. It is currently most used by research institutions. We sustain the development of cell therapies that have the potential to fundamentally improve healthcare.

  • Cell expansion system

    Cell expansion system

  • Cell therapy fill and finish system

    Cell therapy fill and finish system

Cell Therapy Technologies

Autologous Biologics

By harnessing the potential of a patient’s own plasma, bone marrow, or adipose tissue, patients can have more treatment options. We provide the systems for separating, concentrating, and processing autologous cells in clinical settings.

Platelet-rich plasma collection system

Platelet-rich plasma collection system

utologous Biologics

Related Links

T
O
P